Human acetyltransferase polymorphisms
- 1 May 1997
- journal article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 376 (1-2) , 61-70
- https://doi.org/10.1016/s0027-5107(97)00026-2
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Genotyping of the polymorphic N-acetyltransferase (NAT2*) gene locus in two native African populationsPharmacogenetics, 1996
- A slow acetylator genotype is a risk factor for sulphonamide-induced toxic epidermal necrolysis and Stevens-Johnson syndromePharmacogenetics, 1995
- Arylamine-Nucleoside Adduct Formation: Evidence for Arylnitrene Involvement in the Reactions of an N-AcetoxyarylamineChemical Research in Toxicology, 1994
- Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymesHuman Molecular Genetics, 1994
- Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferasesCarcinogenesis: Integrative Cancer Research, 1993
- Xenobiotic metabolism by prostaglandin H synthasePharmacology & Therapeutics, 1992
- Metabolic activation of carcinogensPharmacology & Therapeutics, 1992
- Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver.Journal of Clinical Investigation, 1990
- Acetylator genotype and arylamine-induced carcinogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1988
- ROLE OF N-ACETYLTRANSFERASE PHENOTYPES IN BLADDER CARCINOGENESIS: A PHARMACOGENETIC EPIDEMIOLOGICAL APPROACH TO BLADDER CANCERThe Lancet, 1982